Cargando…
Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
BACKGROUND: The Infectious Diseases Society of America published in 2000 practical guidelines for the management of cryptococcosis. However, treatment strategies have not been fully validated in the various clinical settings due to exclusion criteria during therapeutic trials. We assessed here the o...
Autores principales: | Dromer, Françoise, Bernede-Bauduin, Claire, Guillemot, Didier, Lortholary, Olivier |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483933/ https://www.ncbi.nlm.nih.gov/pubmed/18682846 http://dx.doi.org/10.1371/journal.pone.0002870 |
Ejemplares similares
-
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal
por: Loyse, Angela, et al.
Publicado: (2013) -
An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine
por: Fujimoto, Shusaku, et al.
Publicado: (2020) -
Clonal Population of Flucytosine-Resistant Candida tropicalis from Blood Cultures, Paris, France
por: Desnos-Ollivier, Marie, et al.
Publicado: (2008) -
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007) -
Flucytosine and Amphotericin B Coadministration Induces Dose-Related Renal Injury
por: Folk, Alexandra, et al.
Publicado: (2017)